| Name | Address | City |
|---|---|---|
| Tulsa Comprehensive Treatment Center | 5550 S Garnett Rd #200 | Tulsa |
| Tulsa Rightway Medical | 3445 S. Sheridan Road | Tulsa |
| Tulsa Rightway Medical | 3445 S Sheridan Road E | Tulsa |
| Echota Behavioral Health – Tulsa | 2727 E Admiral Pl | Tulsa |
No results found!
Medication treatment for opioid use disorder in Tulsa
Tulsa is one of the better-served parts of Oklahoma for opioid use disorder (OUD) treatment. As the seat of Tulsa County and the state’s second-largest city, it has both opioid treatment programs (OTPs), the clinics that dispense methadone, and office-based providers who prescribe buprenorphine and naltrexone. That means you can usually choose the medication and the setting that fit your life rather than taking whatever is nearest. The listings above show providers in and around the city. If you want to talk through your options first, the helpline on this page can point you toward a next step.
Your medication options and where each one comes from
Three medications are approved for OUD, and where you get them differs. Methadone for OUD is provided only through a licensed opioid treatment program, not a regular pharmacy, so it involves going to an OTP, at least at first. Buprenorphine, including Suboxone and other buprenorphine-naloxone products, plus the extended-release monthly injection Sublocade, can be prescribed in a doctor’s office and filled at a pharmacy, or provided inside an OTP. Naltrexone, including the monthly Vivitrol injection, can be prescribed by any licensed provider, but it starts only after you have been off opioids for a set time, so a clinician plans the timing with you.
The two settings behind those medications are the OTP, a clinic built around daily or take-home dosing, and office-based opioid treatment (OBOT), which works more like a regular doctor’s visit with a pharmacy pickup. If you are weighing which route to take, it helps to read how methadone and Suboxone compare and to review what an opioid treatment program actually involves before you call. Which one is right is a decision to make with a clinician, and no single medication is the “best” for everyone.
Starting treatment, and what the first visit is like
The first step is an intake assessment: a provider reviews your history, confirms a diagnosis, and starts you on a medication the same day where the program allows it. Bring an ID and insurance information if you have them, but not having them should not stop you from calling. If you have been using fentanyl, timing matters for buprenorphine. Starting it too soon after fentanyl can trigger sudden, sharp withdrawal (called precipitated withdrawal), so a clinician plans when to take the first dose, and some people are directed toward methadone instead. This is worth raising on the first call. You can read more about methadone treatment when fentanyl is involved and about opioid treatment more broadly.
Take-home doses, telehealth, and the current rules
Federal rules updated in 2024 expanded take-home methadone, up to a 28-day supply for patients who are stable in treatment, on a graduated schedule earlier on. The same update let treatment start by telehealth and removed the old requirement that a person have a year-long history of addiction before being admitted. Take-home eligibility is decided by the program based on your progress, not fixed by a calendar. As of July 2026, buprenorphine can also be started through telehealth, including by phone in many cases, without a prior in-person visit; those flexibilities run through the end of 2026 and are still being finalized, so confirm what is current with a provider. Methadone for OUD is still dispensed through an OTP. If you are transferring in or restarting, staying on your dose matters, and long-term methadone treatment is legitimate, effective care.
Paying for treatment in Oklahoma
SoonerCare, Oklahoma’s Medicaid program, covers medication treatment for OUD, including methadone at opioid treatment programs and buprenorphine and naltrexone in office-based settings. Since April 2024, many members receive benefits through SoonerSelect health plans, run by Aetna Better Health of Oklahoma, Humana Healthy Horizons, and Oklahoma Complete Health, so it is worth confirming that a program is in your plan’s network. Buprenorphine products may require prior authorization through SoonerCare pharmacy benefits. If you have private insurance or Medicare, both cover OUD treatment as well. If you are uninsured, ask providers about self-pay rates, sliding-scale fees, and services supported by state and federal grant funding, which Oklahoma uses to cover care for people who cannot pay.
Overdose prevention and harm reduction in Tulsa
Naloxone, the medication that reverses an opioid overdose, is available in Oklahoma over the counter, through a statewide pharmacy standing order, and free through community programs. The state’s OK I’m Ready campaign ships free naloxone kits and fentanyl test strips statewide, and ODMHSAS stocks free-supply vending machines. Oklahoma’s Good Samaritan law protects someone who calls 911 for an overdose from certain drug-possession charges. Tulsa also has its own effort: the Zero Overdose learning community, launched by the Healthy Minds Policy Initiative in March 2023, brings together local behavioral health providers and first responders, and has placed harm-reduction boxes with free naloxone and test strips at Tulsa Fire Department stations in high-need areas. Because fentanyl is frequently mixed into methamphetamine and counterfeit pills here, carrying naloxone matters even for people who do not think they use opioids. A return to use is a common, manageable part of recovery, not a failure, and knowing the signs of an overdose helps keep someone alive long enough to get back to treatment.
The local overdose picture
Overdose has hit Tulsa County hard. The Oklahoma State Department of Health reported 913 unintentional drug overdose deaths among county residents from 2018 to 2022, with fentanyl involved in 313 of them and methamphetamine in 502, and the county’s overdose death rate rose 45% over the prior five-year period (OSDH, 2024). Statewide, there are signs of progress: fentanyl overdose deaths fell 34%, from 730 in 2023 to 487 in 2024 (Oklahoma State Department of Health, 2025). Numbers like these describe real losses in Tulsa neighborhoods, and they are also the reason effective treatment is worth starting now. Methadone and buprenorphine substantially lower the risk of a fatal overdose, and both are available in the city. You can learn more about how opioid use disorder affects the body and why medication helps.
Pregnancy, reentry, and other specific situations
Some situations need a provider with specific experience. For pregnant patients, both methadone and buprenorphine are the recommended standard of care, and treatment lowers the risk to parent and baby; a clinician manages neonatal opioid withdrawal syndrome (NOWS) if it occurs. Oklahoma’s STAR (Substance use Treatment and Recovery) Prenatal Clinic, run by ODMHSAS, provides pregnancy care built around substance use treatment, and the state uses a Plan of Safe Care and a notification pathway meant to support parents in recovery rather than default to a child-welfare report. Getting into treatment is protective, and fear of reporting should not keep you from care. For people leaving jail, when an incarcerated person with OUD is identified, ODMHSAS coordinates a referral to a local provider within about two weeks of release so medication continues on the outside. If you are helping someone you love take this step, our guide for families supporting a person in treatment and information on methadone during pregnancy can help.
Common questions about treatment in Tulsa
Do I have to go to a clinic every day for methadone?
At first, usually yes, because methadone for OUD is dispensed through an opioid treatment program. As you stabilize, federal rules updated in 2024 allow take-home doses, up to a 28-day supply for stable patients, decided by your program. Buprenorphine and naltrexone do not require daily clinic visits.
Can I get same-day treatment?
Some Tulsa providers start medication at the first visit, especially for buprenorphine. Availability varies by program, so call the providers listed above and ask directly about same-day or next-day intake.
Is methadone just trading one drug for another?
No. That framing is inaccurate. Methadone and buprenorphine are prescribed, steady-dose medications that stop withdrawal and cravings without the cycle of illicit use, and major health authorities consider them frontline treatment. You can read more on how methadone works in the body.
Can I start buprenorphine by phone?
As of July 2026, yes, in many cases. Telehealth rules allow buprenorphine to be started remotely, including by phone, without a prior in-person visit, through at least the end of 2026. A Tulsa provider can tell you what applies to your situation.
Will treatment show up to my employer?
Substance use treatment records carry strong federal privacy protections. Ask any provider how they handle confidentiality, and see why staying on your prescribed dose matters if you are worried about disruancy.
Sources and disclosures
Last reviewed July 2026.
Sources:
- Oklahoma State Department of Health, Injury Prevention Service, Tulsa County Drug Overdose Fact Sheet, 2024.
- Oklahoma State Department of Health, Drug Overdose Data, 2025.
- Oklahoma Health Care Authority, SoonerCare and SoonerSelect behavioral health coverage.
- Oklahoma Department of Mental Health and Substance Abuse Services (ODMHSAS), Medications for Opioid Use Disorder; STAR Prenatal Clinic; jail-release MOUD coordination.
- ODMHSAS / OK I’m Ready, naloxone and fentanyl test strip access.
- Healthy Minds Policy Initiative, Zero Overdose Tulsa learning community, 2023.
- SAMHSA and DEA, federal MOUD regulations, including the 2024 revision of 42 CFR Part 8 and 2025-2026 buprenorphine telehealth rules.
- U.S. Food and Drug Administration, approved medications for opioid use disorder.
Methadone Centers is a treatment-discovery and education resource, not a medical provider. The information here is educational and is not a diagnosis or a treatment recommendation; decisions about medication and care should be made with a licensed clinician.
Some listings and the helpline connection on this site are sponsored. Calls may be routed to a participating treatment provider. Using this site does not guarantee admission to any specific program.